Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Basilea erhält Vorabzahlung in Höhe von GBP 146 Mio. (rund CHF 225 Mio.) Basel, 23. Juli 2012 - Basilea Pharmaceutica AG (SIX:BSLN) gab heute nach Erhalt der Zustimmung der Wettbewerbsbehörden...
-
Basilea receives GBP 146 million (approximately CHF 225 million) upfront payment Basel, Switzerland, July 23, 2012 - Basilea Pharmaceutica Ltd. (SIX:BSLN) today reported that the transaction...
-
Die Zulassung ist der erste grosse Fortschritt für US-Patientinnen mit HR-positivem fortgeschrittenen Brustkrebs seit der Einführung von Aromatasehemmern vor über 15 Jahren[1] In einer...
-
Cette autorisation marque la première avancée décisive pour les patientes souffrant d'un cancer du sein avancé HR+ aux Etats-Unis depuis l'introduction des inhibiteurs de l'aromatase il y a plus...
-
Approval represents the first major advance for US patients with advanced HR+ breast cancer since aromatase inhibitors were introduced more than 15 years ago[1] In a Phase III trial, Afinitor...
-
Horgen, 20. Juli 2012 - Die zu 3A Composites gehörende Airex Composites Structures in Altenrhein hat den am 23. Mai 2012 bekannt gegebene Verkauf des Teilbereiches Automotive per 20. Juli 2012...
-
Horgen, July 20, 2012 - The divestment of the Automotive Business of Airex Composites Structures in Altenrhein, part of 3A Composites, as announced on May 23, 2012, was closed as of July 20, 2012. ...
-
Dear Investors and Analysts, Please be reminded that Clariant is to present its Second Quarter / First Half 2012 Results on July 26, 2012. To make an early registration please click on the link...
-
Dear Investors and Analysts, Please be reminded that Clariant is to present its Second Quarter / First Half 2012 Results on July 26, 2012. To make an early registration please click on the...
-
Group net sales increased 1% in constant currencies (cc), with growth in recently launched products more than offsetting loss from Diovan patent expiration Group net sales of USD 14.3 billion...